Lindsay Cala
Sports Medicine · Parachute, CONPI 1437598083
Payments from drug & device makers
Across 272 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$970
- AstraZeneca$397
- GSK$374
- Pfizer$362
- Amgen$308
- Lilly USA, LLC$241
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,95099%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $970 |
| AstraZeneca | 23 | $397 |
| GSK | 19 | $374 |
| Pfizer | 20 | $362 |
| Amgen | 15 | $308 |
| Lilly USA, LLC | 16 | $241 |
| Johnson & Johnson | 14 | $212 |
| Novo Nordisk | 12 | $202 |
| Lundbeck LLC | 7 | $198 |
| Astellas Pharma US Inc | 8 | $153 |
| Avanir Pharmaceuticals, Inc. | 2 | $137 |
| Boehringer Ingelheim | 6 | $133 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $132 |
| Otsuka America Pharmaceutical, Inc. | 6 | $130 |
| Sanofi-aventis U.S. LLC | 7 | $113 |
| Eisai Inc. | 6 | $111 |
| Harmony Biosciences LLC | 5 | $98 |
| Biohaven Pharmaceuticals, Inc. | 4 | $83 |
| Neurocrine Biosciences, Inc. | 3 | $80 |
| Biodelivery Sciences International, Inc. | 5 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| Merck | 3 | $53 |
| Nestle Healthcare Nutrition Inc. | 3 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Dexcom, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 2 | $27 |
| Bayer | 2 | $25 |
| GE HealthCare | 1 | $23 |
| Vertex | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Medtronic | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUEDEXTA$125
How this compares
$4,997 in reported general payments places this provider in the 50th percentile of 196 sports medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 36 | $46,332 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 12 | $45,204 |
| EliquisApixaban | 26 | $41,470 |
| VraylarCariprazine Hcl | 20 | $29,708 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 31 | $27,441 |
| TrulicityDulaglutide | 18 | $21,507 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $18,568 |
| OzempicSemaglutide | 14 | $13,690 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $8,356 |
| Advair HfaFluticasone Propion/Salmeterol | 23 | $6,833 |
| Varenicline Tartrate | 29 | $6,735 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $5,024 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $4,569 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $3,119 |
| Gabapentin | 139 | $2,963 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $241 | $67,84054 claims |
| PfizerEliquis | $362 | $41,47026 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $397 | $32,00944 claims |
| AbbVieVraylar | $970 | $29,70820 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $374 | $26,92437 claims |
| Novo NordiskOzempic | $202 | $13,69014 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $20 | $1,841174 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 196 sports medicine providers in Colorado.
Other sports medicine in Parachute
- Peter MillettVail$22.2M
- Matthew ProvencherVail$4.2M
- Rachel FrankAurora$1.8M
- Alan NgDenver$1.6M
- David WeinsteinColorado Springs$1.5M
- Christopher JonesColorado Springs$1.2M
- James GenuarioParker$751K
- David SchneiderGolden$746K
- Randall ViolaVail$551K
- Jonathan BravmanAurora$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.